Lung Neoplasm — Trials

Lung Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,600 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 101–150 of 1,268 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06173505	Study of Vudalimab or Pembrolizumab in Combination With Chemotherapy as First-line Treatment in Patients With Advanced NSCLC	terminated	Phase 1 / Phase 2	28	Xencor, Inc.INDUSTRY	8	Mar 13, 2026	clinicaltrials
NCT04832854	A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer	terminated	Phase 2	50	Hoffmann-La RocheINDUSTRY